SRNE

Sorrento Therapeutics, Inc.
SRNE

Overview Fund Activity
Delisted

SRNE was delisted on the 22nd of February, 2023.

Back to rankings

9 hedge funds and large institutions have $26.1K invested in Sorrento Therapeutics, Inc. in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
-25
Holders Change %
-73.53%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SW
SlateStone Wealth
Florida
+$3.36K
2
HNB
Huntington National Bank
Ohio
+$716

Top Sellers

1
PP
Paloma Partners
Connecticut
-$1.36M
2
OCM
Oaktree Capital Management
California
-$48.2K
3
OFA
Oaktree Fund Advisors
California
-$23.8K
4
CGA
Crescent Grove Advisors
Illinois
-$21.6K
5
LCM
Lattice Capital Management
Washington
-$18.6K
Name Holding Trade Value Shares
Change 		Shares
Change %
Baillie Gifford & Co
26
Baillie Gifford & Co
United Kingdom
– -$1.34K -3,711 Closed
PP
27
Pacifica Partners
Canada
– -$1.29K -3,500 Closed
HDIM
28
Hanson & Doremus Investment Management
Vermont
– -$1K -3,000 Closed
Nisa Investment Advisors
29
Nisa Investment Advisors
Missouri
– -$1K -2,886 Closed
SPIA
30
Steward Partners Investment Advisory
New York
– -$720 -2,000 Closed
AWM
31
Accel Wealth Management
Iowa
– -$540 -1,500 Closed
SWA
32
SOA Wealth Advisors
New York
– -$522 -1,451 Closed
1
2